Patients sites
ISMAAP
The International Self-Monitoring Association of oral Anticoagulated Patients (ISMAAP) was first proposed in Paris, France, in July 2001. It was officially founded in Geneva, Switzerland, in July 2002 on the initiative of representatives of National Associations of patients on oral anticoagulation therapy.
In some countries, doctors generally or the thrombosis service agree that patients should manage the self-monitoring of long-term oral anticoagulation on their own and take control of their anticoagulation therapy. In these countries, reimbursement of the necessary equipment for self-monitoring is usually granted by the national health insurance authority.
However, in other countries, self-monitoring of long-term oral anticoagulation can be carried out only in very close cooperation with the general practitioner and/or the lab. In these countries, reimbursement by the national health insurance authority of the necessary equipment is for self-monitoring not yet possible.
The main activities of ISMAAP focus on patients on long-term oral anticoagulation, motivating them to take control of their own oral anticoagulation therapy and consequently achieve a better quality of therapy and an improved quality of life. Accordingly, the Association intends to issue patient guidelines that take into account the culture of international groups and the different status of patiens (age, educational level, family environment, etc.).
Objectives
ISMAAP aims to give patients continuous support about life on oral anticoagulation therapy and to motivate them to carry out self-monitoring to reduce the potential risks of thrombosis and haemorrhage.